Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-15-005342
Filing Date
2015-04-01
Accepted
2015-04-01 12:32:13
Documents
1
Period of Report
2015-03-30

Document Format Files

Seq Description Document Type Size
1 rrd424008.html 4  
1 rrd424008.xml 4 3891
  Complete submission text file 0001181431-15-005342.txt   5428
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Issuer) CIK: 0001369786 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SAGENT PHARMACEUTICALS,INC. 1901 N. ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address
Logerfo Michael (Reporting) CIK: 0001518010 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 15742121